|
|
|
 |
|
|
 |
 |
Afexa Life Sciences Incorporated
Company
Snapshot Purchase a Full Report on this Company
Business Description:
Afexa Life Sciences Inc. is a life sciences and technology company. The Company has developed, commercialized and patented a technology, ChemBioPrint, which is used in the discovery and biological standardization of natural products. The Company's lead product, COLD-FX, is designed to aid in the prevention and relief of colds and flu by strengthening the immune system. On October 30, 2009, the Company announced the official launch of IMMUNITY-FX for year round immune health support. IMMUNITY-FX is designed as a daily immune booster to help consumers stay healthy and is comprised of a special formulation to help the immune system fight germs and pathogens that are foreign to the body.
|
|
| |
Wright Quality Rating:
LCNN Rating Explanations |
| |
|
| |
|
| |
|
| |
|
| |
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (7/23/2010):
.47
(Figures in
Canadian Dollars) |
|
1 Week |
-2.1% |
|
13 Weeks |
2.2% |
|
|
|
|
|
|
|
|
|
4 Weeks |
2.2% |
|
52 Weeks |
28.8% |
|
|
|
| |
| |
Afexa Life Sciences Incorporated
Key Data: |
|
|
|
| |
Ticker: |
FXA |
Country: |
CANADA |
| |
|
| |
Exchanges: |
TOR |
Major Industry: |
Drugs, Cosmetics & Health Care |
| |
|
| |
|
|
Sub Industry: |
Ethical Drug Manufacturers |
| |
|
| |
2010
Sales |
68,748,000
(Year Ending Jan 2011). |
Employees: |
107 |
| |
|
| |
Currency: |
Canadian Dollars |
Market Cap: |
49,117,195 |
| |
|
| |
Fiscal Yr Ends: |
March |
Shares Outstanding: |
104,504,670 |
| |
|
| |
Share Type: |
Common |
Closely Held Shares: |
6,688,299 |
|
| |
|
| |
| |
|
|
|
|
| |
Purchase a Full Subscription to All Reports From CorporateInformation: |
|
|
|
| |
The following reports, available for Afexa Life Sciences Incorporated, are typical of the content provided on all companies
covered in CorporateInformation.com
Basic Reports
Afexa Life Sciences Incorporated company Profile (Business Description, Price/Earnings, Price/Sales,
Price/Book, Dividend Yield, Company Officers, Contact Information), Competitor Analysis and up to ten-year history of Sales, Earnings per Share,
Dividends per Share, Security Price and Key Ratios. View Samples
Financial Statement Reports
Research reports that analyze Afexa Life Sciences Incorporated Income Statement and Balance Sheet along with
the Sources of Capital for a five-year period. View Samples
Financial Ratio Reports
Analyses reports that highlight Afexa Life Sciences Incorporated
Accounting Ratios, Asset Utilization, Fixed Charges Coverage, Liquidity, Leverage, Profitability,
Employee Efficiency and Per-Share Data over a five-year period. View Samples
Wright Quality Analyses Reports
Wright’s proprietary rating of corporate quality. The reports include a detailed
analysis of Afexa Life Sciences Incorporated Equity, Liquidity, Financial Strength,
Profitability and Corporate Growth. View Samples |
| |
|
|
| |
|
|
|
 |
|
|
|
|
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|